CME and CFTC Engage in Bitter Dispute Over On-Chain Perpetual Futures

The ongoing feud between the Commodity Futures Trading Commission and the CME Group, the largest derivatives exchange operator in the US, is escalating over the regulator's decision to allow blockchain-based perpetual futures products. The CME has filed a lawsuit against the CFTC, arguing that these products, known as perps, are harmful to its traditional futures contracts and that the regulator has mislabeled them. Perps are decentralized derivative contracts that enable users to speculate on an asset's price with leverage and no expiration date. The CFTC's approval of perps has sparked a debate, with some arguing that it is a diversion from the law, while others see it as a necessary step to allow innovation in the rapidly growing arena. The dispute has significant implications for the US approach to the crypto market, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CME claims that the CFTC's sudden embrace of perps did not consider the ramifications and that the products are not compliant with existing regulations. The regulator, on the other hand, argues that it has the authority to approve these products and that the CME is attempting to stifle innovation. The lawsuit has sparked a heated debate, with some arguing that the CME is trying to maintain its dominance in the market, while others see the regulator's move as a necessary step to allow competition. The outcome of the dispute is uncertain, but it is likely to have a significant impact on the future of the crypto market in the US.